pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 7·2 min read
save

STAT+: More political interference at the FDA?

A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newsletter.

May 7, 2026·read at STAT ↗

STAT PlusNewsletterD.C. Diagnosis More political interference at the FDA? You’re reading STAT’s D.C.

Diagnosis newsletter Manage alerts for this article Email this article Share this article By John WilkersonMay 7, 2026 Washington Correspondent John Wilkerson[email protected]John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter.

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

This is a photo of a young RFK Jr. trying to ride a small rhino. Send news tips and RINO jokes to [email protected] or John_Wilkerson.07 on Signal.Advertisement Former DOGE co-founder v.

former state Covid-19 czar Although most people whom DOGE fired from HHS probably don’t live in Ohio, they may feel a personal connection to the gubernatorial race there. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%!

2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In chronic disease, Congress, drug development, FDA, Mental Health, Pharmaceuticals, Policy, public health, STAT+ Submit a correction requestReprints John Wilkerson Washington Correspondent John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C.

Diagnosis newsletter. Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended D.C.

Diagnosis May 5, 2026 STAT Plus: A new attack on AMA’s billing codes D.C. Diagnosis April 30, 2026 STAT Plus: Democrats go hard on health care affordability Advertisement D.C. Diagnosis April 23, 2026 STAT Plus: RFK Jr.

backs off some MAHA issues D.C. Diagnosis April 21, 2026 STAT Plus: RFK Jr. to face four GOP doctors at Senate hearings D.C.

Diagnosis April 16, 2026 STAT Plus: RFK Jr. begins his testimony marathon Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
410 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Sanofi
topics
ApprovalPsychiatry & CNS

related stories

  • Jul 13STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and moreSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 6STAT+: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with reviewSTAT
  • Apr 27STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trialSTAT
  • Apr 24STAT+: Sanofi MS drug gets positive review in Europe following FDASTAT